ARTICLE | Company News
Soligenix, Harvard deal
January 2, 2012 8:00 AM UTC
Harvard granted Soligenix an option to negotiate a license for exclusive rights to a patent covering prophylactic uses of a modified anthrax toxin protein for use in an anthrax vaccine. Development o...